Cambridge Investment Research Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-36,715	Closed	-$517K	–	2175
2017 Q3	$517K	Hold	36,715	–	–	0.01%	1240
2017 Q2	$274K	Sell	36,715 -200	-0.5%	-$1.31K	﹤0.01%	1559
2017 Q1	$240K	Hold	36,915	–	–	﹤0.01%	1519
2016 Q4	$164K	Hold	36,915	–	–	﹤0.01%	1537
2016 Q3	$172K	Hold	36,915	–	–	﹤0.01%	1596
2016 Q2	$243K	Buy	36,915 +196	+0.5%	+$1.39K	0.01%	1292
2016 Q1	$234K	Hold	36,719	–	–	0.01%	1316
2015 Q4	$221K	Buy	36,719 +1,000	+3%	+$5.72K	0.01%	1308
2015 Q3	$214K	Hold	35,719	–	–	0.01%	1223
2015 Q2	$244K	Hold	35,719	–	–	0.01%	1166
2015 Q1	$217K	Hold	35,719	–	–	0.01%	1205
2014 Q4	$248K	Hold	35,719	–	–	0.01%	1096
2014 Q3	$291K	Hold	35,719	–	–	0.01%	1110
2014 Q2	$290K	Buy	+35,719	New	+$271K	0.01%	1021

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cambridge Investment Research Advisors's SPPI Position: Q4 2017 in Review

Cambridge Investment Research Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 36,715 shares — an estimated $517K sold.

Cambridge Investment Research Advisors first reported a position in SPPI in Q2 2014 and held it in 14 quarters. The position peaked at $517K in Q3 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

Cambridge Investment Research Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Cambridge Investment Research Advisors sold 36,715 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $517K.
Cambridge Investment Research Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2014 and held it in 14 quarters.
Cambridge Investment Research Advisors's Spectrum Pharmaceuticals Inc position peaked at $517K in Q3 2017.
157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2017, filed 22 Feb 2018.